A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy Participants

NCT05638282 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Cendakimab
DRUG: Placebo

Sponsor

Bristol-Myers Squibb